Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Federal contract awards · 10 contracts · Updated 2026-03-30
Total Awards
$230.3M
Contract Count
10
Avg Award Size
$23.0M
Top Agency
Dept. Health and Human Services
Federal Contracts Intelligence · Sprytne.com
CERUS CORP (CERS) has received $230.3M in federal government awards across 10 contracts. The primary contracting agency is the Department of Health and Human Services ($228.9M · 4 awards). Contracts span 2 federal agencies.
Source: USASpending.gov — Federal Award Data · Last updated 2026-03-30
| Agency | Contracts | Total Value |
|---|---|---|
| Department of Health and Human Services | 4 | $228.9M |
| Department of Defense | 6 | $1.4M |
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
$185.5M
LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM
$32.1M
BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD
$11.1M
INTERCEPT PLATELET PROCESSING SETS
$296K
INTERCEPT PLATELET PATHOGEN REDUCTION SETS AT TAMC, HI
$258K
INTERCEPT PLATELET PROCESSING SET
$233K
(R) CERUS CORPORATION:1188061 [26-000202]
$224K
INT PLATELET SET-SMALL, PART NO INT2130B
$218K
INTERCEPT PLATELET PROCESSING SET
$190K
CERUS CORPORATION DROP SHIPMENTS OF MEDICAL SUPPLIES
$186K
CERUS CORP has received $230.3M across 10 federal contract awards according to USASpending.gov data.
The Department of Health and Human Services is the top contracting agency for CERUS CORP with $228.9M across 4 awards.
The average federal contract award for CERUS CORP is $23.0M, based on 10 total awards totaling $230.3M.
SEC Profile
CERUS CORP
Financials, filings & executives
All Contractors
Federal Contract Database
Top US government contractors
SEC Companies
US Company Directory
5,200+ SEC-registered companies
Source: USASpending.gov — Federal Award Data. Reflects top contract awards. Does not include all federal spending categories.